Analysts recommendations

Wacker Neuson: Aliaksandr Halitsa from Hauck & Aufhauser retains his positive opinion on the stock with a Buy rating. The target price has been raised from EUR 23.50 to EUR 32. Price €25,13.

Orsted: RBC upgrades his rating from Neutral to Buy. No major update to the target price set at DKK 1025 compared to DKK 1050. Price DKK862,20.

Ryanair: In a research note published by Patrick Creuset, Goldman Sachs advises its customers to buy the stock. The target price is reviewed upwards from EUR 17.90 to EUR 19.20. Price €16,42.

IAG: The analyst Patrick Creuset from Goldman Sachs has published a research note on the case. Initially a Buy, the broker is now neutral. The target price has been revised upwards and is now set at GBX 204, compared with GBX 190 previously. Price GBX200,10.

Gea Group: The broker Goldman Sachs lowers its recommendation and switches to sell against neutral previously. The target price has been revised downwards and is now set at EUR 28 as compared to EUR 32 previously. Price €33,95.

Lufthansa: Goldman Sachs is revising its board downwards. The broker is now advising to sell against neutral previously. The target price is reduced from EUR 9.40 to EUR 8.10. Price €10,51.

Roche: In his latest research note, analyst Keyur Parekh confirms his positive recommendation. The broker Goldman Sachs is keeping its Buy rating. The target price remains unchanged at CHF 432. Price CHF329,60.

Biogen: Piper Sandler Adjusts Biogen’s Price Target to $384 From $260, Maintains Neutral Rating. Price $395,85.

Biogen: Bernstein Adjusts Biogen PT to $380 From $270, Maintains Market Perform Rating. Price $395,85.

Moderna: Piper Sandler Adjusts Moderna’s Price Target to $246 From $231, Maintains Overweight Rating. Price $219,57.